Tag Archives: Debjit Chattopadhyay

H.C. Wainwright Reiterates a Buy Rating on Hookipa Pharma (HOOK)

In a report released today, Debjit Chattopadhyay from H.C. Wainwright reiterated a Buy rating on Hookipa Pharma (HOOK – Research Report), with a price target of $15.00. The company’s shares closed last Monday at $11.78. According to TipRanks.com, Chattopadhyay is

Hookipa Pharma (HOOK) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Buy rating on Hookipa Pharma (HOOK – Research Report) today and set a price target of $15.00. The company’s shares closed last Tuesday at $11.51. According to TipRanks.com, Chattopadhyay is a 5-star analyst

Autolus Therapeutics (AUTL) Received its Third Buy in a Row

After William Blair and Mizuho Securities gave Autolus Therapeutics (NASDAQ: AUTL) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst Debjit Chattopadhyay reiterated a Buy rating on Autolus Therapeutics today and set a

Analysts Offer Insights on Healthcare Companies: Harpoon Therapeutics (NASDAQ: HARP), Denali Therapeutics (NASDAQ: DNLI) and AVEO Pharma (NASDAQ: AVEO)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Harpoon Therapeutics (HARP – Research Report), Denali Therapeutics (DNLI – Research Report) and AVEO Pharma (AVEO – Research Report) with bullish sentiments.

H.C. Wainwright Keeps a Buy Rating on ImmunoGen (IMGN)

In a report released today, Debjit Chattopadhyay from H.C. Wainwright reiterated a Buy rating on ImmunoGen (IMGN – Research Report), with a price target of $9.00. The company’s shares closed last Friday at $4.68. According to TipRanks.com, Chattopadhyay is a

H.C. Wainwright Sticks to Their Buy Rating for Galapagos (GLPG)

H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Buy rating on Galapagos (GLPG – Research Report) today and set a price target of $270.00. The company’s shares closed last Wednesday at $221.27. According to TipRanks.com, Chattopadhyay is a 5-star analyst with